Literature DB >> 29411597

Developing a vaccine for leishmaniasis: how biology shapes policy.

Karl Erik Müller, Carl Tollef Solberg, Juliana Ide Aoki, Lucile Maria Floeter-Winter, Audun Helge Nerland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29411597     DOI： 10.4045/tidsskr.17.0620

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN： 0029-2001


× No keyword cloud information.
  3 in total

1.  Murine Susceptibility to Leishmania amazonensis Infection Is Influenced by Arginase-1 and Macrophages at the Lesion Site.

Authors:  Fernanda Tomiotto-Pellissier; Milena Menegazzo Miranda-Sapla; Taylon Felipe Silva; Bruna Taciane da Silva Bortoleti; Manoela Daiele Gonçalves; Virginia Márcia Concato; Ana Carolina Jacob Rodrigues; Mariana Barbosa Detoni; Idessania Nazareth Costa; Carolina Panis; Ivete Conchon-Costa; Juliano Bordignon; Wander Rogério Pavanelli
Journal:  Front Cell Infect Microbiol       Date:  2021-10-01       Impact factor: 5.293

2.  Differential immune response modulation in early Leishmania amazonensis infection of BALB/c and C57BL/6 macrophages based on transcriptome profiles.

Authors:  Juliana Ide Aoki; Sandra Marcia Muxel; Ricardo Andrade Zampieri; Karl Erik Müller; Audun Helge Nerland; Lucile Maria Floeter-Winter
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

Review 3.  Role of Circulating Immune Complexes in the Pathogenesis of Canine Leishmaniasis: New Players in Vaccine Development.

Authors:  Cristina Cacheiro-Llaguno; Nuria Parody; Marta R Escutia; Jerónimo Carnés
Journal:  Microorganisms       Date:  2021-03-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.